SEC Comment Letter for Apollo Endosurgery, Inc. (CIK 0001251769) — May 11, 2021
Apollo Endosurgery, Inc. (CIK 0001251769)
Date: May 11, 2021 · CIK: 0001251769 · Accession: 0000000000-21-005982
AI Filing Summary & Sentiment
File numbers found in text: 333-255786
Letter
United States securities and exchange commission logo May 11, 2021 Charles McKhann Chief Executive Officer and President Apollo Endosurgery, Inc. 1120 S. Capital of Texas Highway Building 1, Suite #300 Austin, Texas 78746 Re:Apollo Endosurgery, Inc. Registration Statement on Form S-3 Filed May 5, 2021 File No. 333-255786 Dear Mr. McKhann: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John T. McKenna, Esq.
Show Raw Text
United States securities and exchange commission logo
May 11, 2021
Charles McKhann
Chief Executive Officer and President
Apollo Endosurgery, Inc.
1120 S. Capital of Texas Highway
Building 1, Suite #300
Austin, Texas 78746
Re:Apollo Endosurgery, Inc.
Registration Statement on Form S-3
Filed May 5, 2021
File No. 333-255786
Dear Mr. McKhann:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John T. McKenna, Esq.